ENANTA PHARMACEUTICALS INC — Director's Dealing 2021

Aug 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-08-19

Reporting Person: Hata Yujiro S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-19	Stock Option (right to buy)	$48.58	A	13144	Acquired	2031-08-19	Common Stock (13144)	Direct

Footnotes

F1: Such option will become exercisable monthly in substantially equal installments over three years, beginning from the date of grant (August 19, 2021).